Inventor · disambiguated record
Oak K. Kim
Also filed as: KIM OAK · KIM OAK K
15 granted patents·13 pending applications·158 citations·filing 1998–2016
93Inventor score
Files withPARATEK PHARM INNC10BRISTOL MYERS SQUIBB CO9ALEKSHUN MICHAEL N2ASSEFA HAREGEWEIN1BRISTOL MEYERS SQUIBB CO1
Top patents by PatentIndex Score
28 records- 0192US7326696B2Amino-methyl substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2003·Granted Feb 5, 2008·69 cites·128 claims
- 0282US6548546B2HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 15, 2003·10 cites·13 claims
- 0378US9481639B2Substituted tetracycline compounds for treatment of inflammatory skin disordersPARATEK PHARM INNC·Filed 2013·Granted Nov 1, 2016·3 cites·10 claims
- 0478US8318706B2Substituted tetracycline compoundsKIM OAK·Filed 2007·Granted Nov 27, 2012·5 cites·10 claims
- 0577US8436031B2Transcription factor modulating compounds and methods of use thereofKIM OAK K·Filed 2009·Granted May 7, 2013·4 cites·3 claims
- 0677US6265584B1Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 24, 2001·15 cites·2 claims
- 0777US6093712ACephalosporin derivativesBRISTOL MEYERS SQUIBB CO·Filed 1998·Granted Jul 25, 2000·21 cites·9 claims
- 0874US6265394B1Bis quaternary MRSA cephem derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 24, 2001·19 cites·22 claims
- 0971US7022667B2O-derivatized nocathiacin derivativesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 4, 2006·5 cites·9 claims
- 1071US6359141B2Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 19, 2002·3 cites·2 claims
- 1162US6486159B2Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 26, 2002·1 cites·17 claims
- 1256US6620934B2Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 16, 2003·1 cites·1 claims
- 1355US6620799B2Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 16, 2003·1 cites·21 claims
- 1455US6458961B1Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Oct 1, 2002·1 cites·4 claims
- 1553US8513223B2Substituted tetracycline compounds for treatment of inflammatory skin disordersASSEFA HAREGEWEIN·Filed 2007·Granted Aug 20, 2013·0 cites·20 claims
- 1653US2008015169A1Amino-methyl substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2007·Application pending·0 cites
- 1752US2005143352A1Substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2004·Application pending·0 cites
- 1848US2006287283A1Prodrugs of 9-aminomethyl tetracycline compoundsPARATEK PHARM INNC·Filed 2006·Application pending·0 cites
- 1948US2017305840A1Substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2016·Application pending·0 cites
- 2047US2002065219A1Water soluble thiazolyl peptide derivativesFiled 2001·Application pending·0 cites
- 2147US2009131481A1Transcription Factor Modulating Compounds and Methods of Use ThereofPARATEK PHARM INNC·Filed 2008·Application pending·0 cites
- 2244US2009170812A1Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2007·Application pending·0 cites
- 2344US2006160799A1Transcription factor modulating compounds and methods of use thereofALEKSHUN MICHAEL N·Filed 2005·Application pending·0 cites
- 2443US2005137174A1Prodrugs of 9-aminomethyl tetracycline compoundsPARATEK PHARM INNC·Filed 2004·Application pending·0 cites
- 2542US2011086822A1Substituted Tetracycline CompoundsNELSON MARK L·Filed 2010·Application pending·0 cites
- 2640US2010249076A1Prodrugs of 9-aminomethyl tetracycline compoundsPARATEK PHARM INNC·Filed 2010·Application pending·0 cites
- 2738US2002049191A1Cephalosporin derivativesFiled 2001·Application pending·0 cites
- 2838US2011059962A1Transcription factor modulating compounds and methods of use thereofALEKSHUN MICHAEL N·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oak K. Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →